Noble E. Jarrell

Array ( [id] => 6428159 [patent_doc_number] => 20100168359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'TRI-FUNCTIONAL UV-ABSORBING COMPOUNDS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/640019 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11948 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168359.pdf [firstpage_image] =>[orig_patent_app_number] => 12640019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488467 [patent_doc_number] => 20110251384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'CYCLIC CARBODIIMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/139103 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13658 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251384.pdf [firstpage_image] =>[orig_patent_app_number] => 13139103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501774 [patent_doc_number] => 20110263616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => '11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE MALEATE SALT' [patent_app_type] => utility [patent_app_number] => 13/133288 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6321 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263616.pdf [firstpage_image] =>[orig_patent_app_number] => 13133288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580948 [patent_doc_number] => 20110294831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => '11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE CITRATE SALT' [patent_app_type] => utility [patent_app_number] => 13/133297 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 6474 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294831.pdf [firstpage_image] =>[orig_patent_app_number] => 13133297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580889 [patent_doc_number] => 20110294772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'USE OF CYCLOSQUARAMIDE COMPOUNDS AS ANTI-TUMOUR AGENTS' [patent_app_type] => utility [patent_app_number] => 13/133939 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5305 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294772.pdf [firstpage_image] =>[orig_patent_app_number] => 13133939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328698 [patent_doc_number] => 08236793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Diazabicyclic aryl derivatives as cholinergic receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/633505 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13359 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12633505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670093 [patent_doc_number] => 20110319362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'STAT3 LIGANDS AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/128941 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20361 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377721 [patent_doc_number] => 20100081623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'NOVEL TELLURIUM COMPOUNDS AND THEIR USE AS IMMUNOMODULATORS' [patent_app_type] => utility [patent_app_number] => 12/629071 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13285 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081623.pdf [firstpage_image] =>[orig_patent_app_number] => 12629071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701564 [patent_doc_number] => 08394786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 12/624637 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62650 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12624637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589379 [patent_doc_number] => 08778920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => '3-cyano-quinoline derivatives with antiproliferative activity' [patent_app_type] => utility [patent_app_number] => 12/624708 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18467 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12624708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749830 [patent_doc_number] => 08841306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Antimicrobials' [patent_app_type] => utility [patent_app_number] => 13/130440 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21677 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13130440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086369 [patent_doc_number] => 08557798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Macrocyclic heterocyclic aspartyl protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/620291 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12687 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12620291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016720 [patent_doc_number] => 20110224193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE' [patent_app_type] => utility [patent_app_number] => 13/129821 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33277 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224193.pdf [firstpage_image] =>[orig_patent_app_number] => 13129821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003723 [patent_doc_number] => 20110118459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'HIGH PERFORMANCE LUMINESCENT COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/619536 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7594 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118459.pdf [firstpage_image] =>[orig_patent_app_number] => 12619536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6295642 [patent_doc_number] => 20100160297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'COMPOUNDS FOR PIM KINASE INHIBITION AND FOR TREATING MALIGNANCY' [patent_app_type] => utility [patent_app_number] => 12/616581 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7606 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160297.pdf [firstpage_image] =>[orig_patent_app_number] => 12616581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594850 [patent_doc_number] => 20100048534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'CRYSTALLINE LESTAURTINIB HYDRATES AND CRYSTALLINE LESTAURTINIB HEMIHYDRATE HEMIACETONITRILEATE AND CRYSTALLINE LESTAURTINIB HEMIHYDRATE HEMITETRAHYDROFURANATE' [patent_app_type] => utility [patent_app_number] => 12/611273 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5391 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048534.pdf [firstpage_image] =>[orig_patent_app_number] => 12611273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431766 [patent_doc_number] => 20100152163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'AZEPINO[4,5-B]INDOLES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/610152 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 119552 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152163.pdf [firstpage_image] =>[orig_patent_app_number] => 12610152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801254 [patent_doc_number] => 08129526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Pyrimidine compound and pests controlling composition containing the same' [patent_app_type] => utility [patent_app_number] => 12/579561 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24187 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129526.pdf [firstpage_image] =>[orig_patent_app_number] => 12579561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167852 [patent_doc_number] => 20110196015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'N 1-2-THIOPHENE-2-YLETHYL-N2-SUBSTITUTED BIGUANIDE DERIVATE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/123296 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10424 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196015.pdf [firstpage_image] =>[orig_patent_app_number] => 13123296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567952 [patent_doc_number] => 20100234356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/577853 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50145 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234356.pdf [firstpage_image] =>[orig_patent_app_number] => 12577853 [rel_patent_id] =>[rel_patent_doc_number] =>)